US Bancorp
LCTX icon

US Bancorp’s Lineage Cell Therapeutics LCTX Stock Holding History

US Bancorp’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9
Closed – – 4139
2021
Q2 		$0 Buy
+9
New +$23 ﹤0.01% 4043
2020
Q2 		– Sell
-44
Closed – – 3809
2020
Q1 		$0 Hold
44
– – ﹤0.01% 3738
2019
Q4 		$0 Hold
44
– – ﹤0.01% 3695
2019
Q3 		$0 Sell
44
-443
-91% -$459 ﹤0.01% 3631
2019
Q2 		$1K Hold
487
– – ﹤0.01% 3554
2019
Q1 		$1K Buy
+487
New +$606 ﹤0.01% 3497

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return